Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Macher

Showing results (71-80 of 87) with videos related to

Pageof 9
Sort By:
Journal of Cancer Research and Clinical Oncology|January 1, 1979
Hepatic failure in a patient treated with dacarbazine (DTIC) for malignant melanomaP J Frosch, B M Czarnetzki, E Macher, et al.
Archives of Dermatology|September 1, 1981
Monoclonal gammopathy in scleredema. Observations in three casesP M Kövary, F Vakilzadeh, E Macher, et al.
Deutsche Medizinische Wochenschrift (1946)|May 9, 1986
[Adjuvant chemotherapy in addition to radical surgical treatment of regional lymph node metastases in malignant melanoma]B M Czarnetzki, V Aragon, E B Bröcker, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1984
Inhibition of the T suppressor circuit of delayed-type hypersensitivity by interferonJ Knop, R Stremmer, U Taborski, et al.
International Journal of Cancer|July 15, 1985
Phenotypic dynamics of tumor progression in human malignant melanomaE B Bröcker, L Suter, J Brüggen, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Long-term adjuvant immunotherapy in stage I high risk malignant melanoma, comparing two BCG preparations versus non-treatment in a randomised multicentre study (EORTC Protocol 18781)B M Czarnetzki, E Macher, S Suciu, et al.
Experimental Cell Biology|January 1, 1989
Characterization and differential expression of an endothelial cell-specific surface antigen in continuous and sinusoidal endothelial, in skin vascular lesions and in vitroS Goerdt, F Steckel, K Schulze-Osthoff, et al.
Der Radiologe|July 1, 1988
[Sensitivity and specificity of sonographic diagnosis of the lymph nodes in malignant melanoma]J D Löhnert, G Bongartz, K Wernecke, et al.
International Journal of Cancer|November 15, 1981
Adjuvant reactivity predicts survival in patients with "high-risk" primary malignant melanoma treated with systemic BCG. EORTC Malignant Melanoma Cooperative Group Writing CommitteeA J Cochran, M E Buyse, F J Lejeune, et al.
Dermatologica|January 1, 1977
Paraproteinaemia in Sézary syndromeP M Kövary, H Niedorf, G Sommer, et al.
Pageof 9

Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
Journal of Cancer Research and Clinical Oncology|January 1, 1979
Hepatic failure in a patient treated with dacarbazine (DTIC) for malignant melanomaP J Frosch, B M Czarnetzki, E Macher, et al.
Archives of Dermatology|September 1, 1981
Monoclonal gammopathy in scleredema. Observations in three casesP M Kövary, F Vakilzadeh, E Macher, et al.
Deutsche Medizinische Wochenschrift (1946)|May 9, 1986
[Adjuvant chemotherapy in addition to radical surgical treatment of regional lymph node metastases in malignant melanoma]B M Czarnetzki, V Aragon, E B Bröcker, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1984
Inhibition of the T suppressor circuit of delayed-type hypersensitivity by interferonJ Knop, R Stremmer, U Taborski, et al.
International Journal of Cancer|July 15, 1985
Phenotypic dynamics of tumor progression in human malignant melanomaE B Bröcker, L Suter, J Brüggen, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Long-term adjuvant immunotherapy in stage I high risk malignant melanoma, comparing two BCG preparations versus non-treatment in a randomised multicentre study (EORTC Protocol 18781)B M Czarnetzki, E Macher, S Suciu, et al.
Experimental Cell Biology|January 1, 1989
Characterization and differential expression of an endothelial cell-specific surface antigen in continuous and sinusoidal endothelial, in skin vascular lesions and in vitroS Goerdt, F Steckel, K Schulze-Osthoff, et al.
Der Radiologe|July 1, 1988
[Sensitivity and specificity of sonographic diagnosis of the lymph nodes in malignant melanoma]J D Löhnert, G Bongartz, K Wernecke, et al.
International Journal of Cancer|November 15, 1981
Adjuvant reactivity predicts survival in patients with "high-risk" primary malignant melanoma treated with systemic BCG. EORTC Malignant Melanoma Cooperative Group Writing CommitteeA J Cochran, M E Buyse, F J Lejeune, et al.
Dermatologica|January 1, 1977
Paraproteinaemia in Sézary syndromeP M Kövary, H Niedorf, G Sommer, et al.
Pageof 9